The treatment of pediatric myocarditis is controversial, and the benefits of intravenous
immunoglobulin (IVIG) are inconclusive due to limited data. We searched studies from …

The efficacy of intravenous immunoglobulin (IVIG) in the treatment of acute myocarditis
remains controversial. The aim of this study was to conduct a meta-analysis to assess the …

Background: The efficacy of corticosteroids and intravenous immunoglobulin (IVIG) in
pediatric myocarditis remains controversial. Objectives: The authors performed a meta …

Purpose There is currently little evidence to support intravenous immune globulin (IVIG)
therapy for pediatric myocarditis. The purpose of our retrospective study was to assess the …

We retrospectively studied medical records of all children with acute myocarditis and/or early
DCM admitted to the Pediatric Critical Care Unit of our hospital between January 2010 and …

Background High-dose steroids and intravenous immunoglobulin (IVIG) are controversial
treatments for pediatric patients with acute myocarditis. This study aimed to investigate their …

Background Intravenous gamma globulin (IVGG) is commonly used in the management of
acute myocarditis. The objective of this study was to systematically review the literature …

The use of immunosuppressants in the treatment of myocarditis in children remains
controversial. The aim of this meta-analysis is to summarize the current empirical evidence …

Background: Immunosuppressive therapy is reportedly ineffective in adults with acute
myocarditis. Aims: To systematically review the impact of immunosuppressive therapy on the …

Although an autoimmune mechanism has been postulated for acute encephalitis syndrome
(AES) complicated by myocarditis, immunomodulatory treatment strategies are still under …